Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1250-1256

  Parsons Wingerter, Patricia ^a,c   Elliott, Katherine E ^b   Clark, John I ^a   Farr, Andrew G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b 3Com Corp   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chorioallantoic membrane; Complexity; Fibroblast growth factor receptors; Fractal dimension; Quail

Indexed keywords

ANGIOSTATIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; FRACTAL ANALYSIS; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; QUAIL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

EID: 0034118344     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1250     Document Type: Article

References (48)

1. D'Amore PA, Smith SR. Growth factor effects on cells of the vascular wall: a survey. Growth Factors. 1993;8:61-75.
2. Femig DG, Gallagher JT. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res. 1994;5:353-377.
3. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 1995;9:919-925.
4. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int. 1995;19:431-444.
5. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev. 1997;18:26-45.
6. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol. 1997;75:669-685.
7. Klein S, Roghani M, Rifkin DB. Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. EXS. 1997; 79:159-192.
8. Iruela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost. 1997;78:672-677.
9. Webster MK, Donoghue DJ. FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 1997;13:178-181.
10. Burke D, Wilkes D, Blundell TL, Malcolm S. Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci. 1998;23:59-62.
11. Givol D, Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 1992;6: 3362-3369.
12. Johnson DE, Williams LT. Structural, and functional diversity in the FGF receptor multigene family. Adv Cancer Res. 1993;60:1-41.
13. Green PJ, Walsh FS, Doherty P. Promiscuity of fibroblast growth factor receptors. Bioessays. 1996;18:639-646.
14. Yang EY, Moses HL. Transforming growth factor betal-induced changes in cell migration, proliferation and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol. 1990;111:731-741.
15. Jain RK, Schlenger K, Hockel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med. 1997;3:1203-1208.
16. Parsons-Wingerter P, Lwai B, Yang MC, Elliott KE, Milaninia A, Redlitz A, Clark JI, Sage EH. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res. 1998;55:201-214.
17. Parsons-Wingerter P, Elliott KE, Farr AG, Radhakrishnan K, Clark JI, Sage EH. Generational analysis reveals that TGF-betal inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels. Microvasc Res. 2000;50:221-232.
18. Kassab GS, Lin DH, Fung YC. Morphometry of pig coronary venous system. Am J Physiol. 1994;267(pt 2):H2100-H2113.
19. Kassab GS, Rider CA, Tang NJ, Fung YC. Morphometry of pig coronary arterial trees. Am J Physiol. 1993;265(pt 2):H350-H365.
20. Gan RZ, Tian Y, Yen RT, Kassab GS. Morphometry of the dog pulmonary venous tree. J Appl Physiol. 1993:75:432-440.
21. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci U S A. 1995;92:7657-7661.
22. Pardanaud L, Altman C, Kitos P, Dieterlen-Lievre F, Buck CA. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development. 1987;100:339-349.
23. Coffin JD, Poole TJ. Endothelial cell origin and migration in embryonic heart and cranial blood vessel development. Anat Rec. 1991;231: 383-395.
24. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG. Fibroblast growth factor 2 control of vascular tone. Nat Med. 1998;4:201-207.
25. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol. 1998;153:1641-1646.
26. Ozaki H, Okamoto N, Ortega S, Chang M, Ozaki K, Srinivas S, Vinores MA, Derevjanik N, Zack DJ, Basilico C, Campochiaro PA. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol. 1998;153:757-765.
27. Fulgham DL, Widhalm SR, Martin S, Coffin JD. FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium. 1999;6:185-195.
28. Devlin GP, Fort S, Yu E, Cusimano RJ, Wei K, Rakowski H, Butany J, Richards JA, Sole MJ, Schwanz L. Effect of a single bolus of intracoronary basic fibroblast growth factor on perfusion in an ischemic porcine model. Can J Cardiol. 1999;15:676-682.
29. Bryant SR, Bjercke RJ, Erichsen DA, Rege A, Lindner V. Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ Res. 1999;84:3223-328.
30. Coffin JD, Florkiewicz RZ, Neumann J, Mort-Hopkins T, Dorn GW II, Lightfoot P, German R, Howles PN, Kier A, O'Toole BA. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell. 1995;6: 1861-1873.
31. Naski M, Ornitz DM. FGF signaling in skeletal development. Front Biosci. 1998;3:D781-D794.
32. Hanneken A, Ying W, Ling N, Baird A. Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc Natl Acad Sci U S A. 1994;91:9170-9174.
33. Hanneken A, Maher PA, Baird A. High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells: implications for the modulation of FGF-2. J Cell Biol. 1995;128:1221-1228.
34. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN. An essential role for ectodomain shedding in mammalian development. Science. 1998;282: 1281-1284.
35. Venkataraman G, Raman R, Sasisekharan V, Sasisekharan R. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc Natl Acad Sci U S A. 1999;96:3658-3663.
36. Wang F, Lu W, McKeehan K, Mohamedali K, Gabriel JL, Kan M, McKeehan WL. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex. Biochemistry. 1999;38:160-171.
37. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.
38. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;10:9-22.
39. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995;92: 10457-10461.
40. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A. 1996;93: 4851-4856.
41. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development. 1992;116:435-439.
42. 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996;93:9764-9769.
43. Mandriota SJ, Pepper MS. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci. 1997;110: 2293-2302.
44. Yoshida A, Anand-Apte B, Zetter BR. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors. 1996;13:57-64.
45. Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK. Quantitation and physiological characterization of angiogenic vessels in mice. Am J Pathol. 1996;149:59-71.
46. Seo MS, Kwak N, Ozaki H, Yamada H, Okamoto N, Yamada E, Fabbro D, Hofmann F, Wood JM, Campochiaro PA. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol. 1999;154:1743-1753.
47. Baish JW, Jain RK. Cancer, angiogenesis and fractals. Nat Med. 1998; 4:984. Letter.
48. Coffey DS. Self-organization, complexity and chaos: the new biology for medicine. Nat Med. 1998;4:882-885.